Background:The naturally occurring ␣5(D398N) variant alters smoking behavior, but functional differences have not been detected between ␣34␣5 nAChR harboring these variants. Results: ACh-induced ␣34␣5 nAChR function is lower when ␣5(Asn-398) substitutes for ␣5(Asp-398).
Conclusion:The ␣5 variant-induced change in ␣34␣5 nAChR function may underlie some of the phenotypic changes associated with this polymorphism. Significance: ␣34␣5 nAChR function may be a useful target for smoking cessation pharmacotherapies.Genome-wide studies have strongly associated a non-synonymous polymorphism (rs16969968) that changes the 398th amino acid in the nAChR ␣5 subunit from aspartic acid to asparagine (D398N), with greater risk for increased nicotine consumption. We have used a pentameric concatemer approach to express defined and consistent populations of ␣34␣5 nAChR in Xenopus oocytes. ␣5(Asn-398; risk) variant incorporation reduces ACh-evoked function compared with inclusion of the common ␣5(Asp-398) variant without altering agonist or antagonist potencies. Unlinked ␣3, 4, and ␣5 subunits assemble to form a uniform nAChR population with pharmacological properties matching those of concatemeric ␣34* nAChRs. ␣5 subunit incorporation reduces ␣34* nAChR function after coinjection with unlinked ␣3 and 4 subunits but increases that of ␣34␣5 versus ␣34-only concatemers. ␣5 subunit incorporation into ␣34* nAChR also alters the relative efficacies of competitive agonists and changes the potency of the non-competitive antagonist mecamylamine. Additional observations indicated that in the absence of ␣5 subunits, free ␣3 and 4 subunits form at least two further subtypes. The pharmacological profiles of these free subunit ␣34-only subtypes are dissimilar both to each other and to those of ␣34␣5 nAChR. The ␣5 variant-induced change in ␣34␣5 nAChR function may underlie some of the phenotypic changes associated with this polymorphism.
Nicotinic acetylcholine receptors (nAChR)2 are prototypical members of the ligand-gated ion channel superfamily of neurotransmitter receptors. nAChR exist as a diverse family of molecules composed of different pentameric combinations of homologous subunits derived from at least 17 genes (␣1-␣10, 1-4, ␥, ␦, ⑀). The properties of nAChR are determined by their subunit composition, giving rise to multiple subtypes with a range of overlapping pharmacological and biophysical properties (1). It also has become apparent that different stoichiometries of the same subunits can produce subtypes with distinctly different characteristics, a phenomenon observed in both heterologous and natural expression systems (1-5).Recently, genome-wide association studies have indicated that single-nucleotide polymorphisms (SNPs) within nAChR subunits can substantially affect nAChR-mediated smoking behavior in humans. Most prominent among these single-nucleotide polymorphisms have been those located in the CHRNA5/CHRNA3/CHRNB4 locus, located on chromosome 15q25, which encodes the ␣5, ␣3 and 4 subunits of nicotinic recept...